1. Home
  2. BIOX vs FEMY Comparison

BIOX vs FEMY Comparison

Compare BIOX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

SELL

Current Price

$0.28

Market Cap

23.7M

Sector

Industrials

ML Signal

SELL

FEMY

Femasys Inc.

HOLD

Current Price

$1.74

Market Cap

22.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
FEMY
Founded
2001
2004
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
22.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BIOX
FEMY
Price
$0.28
$1.74
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $14.33
AVG Volume (30 Days)
★ 206.5K
92.3K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
N/A
★ $2,293,313.00
Revenue This Year
$59.25
N/A
Revenue Next Year
$34.94
$328.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$0.28
$0.29
52 Week High
$2.19
$6.29

Technical Indicators

Market Signals
Indicator
BIOX
FEMY
Relative Strength Index (RSI) 24.67 33.87
Support Level N/A $0.40
Resistance Level $0.40 $3.21
Average True Range (ATR) 0.03 0.21
MACD -0.00 -0.02
Stochastic Oscillator 16.58 32.73

Price Performance

Historical Comparison
BIOX
FEMY

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: